New treatment paradigms for ADPKD: moving towards precision medicine
- 9 October 2017
- journal article
- review article
- Published by Springer Nature in Nature Reviews Nephrology
- Vol. 13 (12) , 750-768
Abstract
The natural history of autosomal dominant polycystic kidney disease (ADPKD) is characterized by a variable rate of cyst development and increase in total kidney volume (TKV), variable kidney function decline and age of onset of end-stage renal disease (ESRD), and variable presentation of renal and extrarenal manifestations. Precision medicine is proposed to improve patient outcomes by tailoring therapy to the specific genetic background, pathophysiology, disease burden, prognosis and status of each individual. This approach to the management of patients with ADPKD is nearing clinical implementation owing to advances in genetics, imaging, biomarker development and therapeutics. In this Review, we discuss pharmacological and non-pharmacological interventions for the treatment of hypertension and proteinuria, and for slowing the rate of cyst growth in patients with ADPKD before the development of ESRD. We provide recommendations for the management of renal complications, including cyst infection, nephrolithiasis, haematuria and chronic pain. The early treatment of patients with ADPKD who are largely asymptomatic is associated with a therapeutic burden but slows cyst growth and delays subsequent loss of kidney function, which ultimately delays the need for renal replacement therapy and has a positive effect on the quality of life of patients.Keywords
This publication has 188 references indexed in Scilit:
- Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney DiseaseNew England Journal of Medicine, 2012
- Evaluation of urine biomarkers of kidney injury in polycystic kidney diseaseKidney International, 2012
- Analysis of baseline parameters in the HALT polycystic kidney disease trialsKidney International, 2012
- Intensive Blood-Pressure Control in Hypertensive Chronic Kidney DiseaseNew England Journal of Medicine, 2010
- Hypertension in Autosomal Dominant Polycystic Kidney DiseaseAdvances in Chronic Kidney Disease, 2010
- Percutaneous Nephrolithotomy for Large or Multiple Upper Tract Calculi and Autosomal Dominant Polycystic Kidney DiseaseJournal of Urology, 2010
- Renal injury is a third hit promoting rapid development of adult polycystic kidney diseaseHuman Molecular Genetics, 2009
- Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney diseaseKidney International, 2009
- Determinants of renal volume in autosomal-dominant polycystic kidney diseaseKidney International, 2008
- A Dietary Quality Comparison of Popular Weight-Loss PlansJournal of the American Dietetic Association, 2007